# Antidote A.I. Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/antidote-a-i-health

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.antidotehealth.ai
- Total disclosed funding: $34M
- Latest round: Series A (Mar 22, 2022)
- Investors on record: 4

## About

Antidote A.I. Health, Inc. is a New York-based health technology company that provides accessible virtual healthcare solutions through innovative insurance plans designed to enhance patient care and streamline the healthcare experience.Founded in 2020, Antidote A.I. Health, Inc. specializes in offering virtual healthcare services and individual and family health plans. The company is headquartered in New York, US. Key founders include Avihai Sodri, Ben Enosh, Carine-Belle Feder, and David Ccfp-Em. Antidote A.I. Health has raised USD 22.00 mn in Series A funding on March 22, 2022, with notable investors including Flint Capital, Group 11, and iAngels. This funding round marks the total amount raised by the company, which has completed 6 deals to date.Antidote Health offers comprehensive health plans designed to enhance access to care through unlimited virtual care services. Their core offerings include individual and family health plans that provide expert medical assistance for a range of issues, from routine care to chronic condition management, accessible at any time. The company’s innovative approach allows members to consult with virtual clinicians through the Antidote app, which simplifies healthcare management by enabling users to review claims, schedule appointments, and connect with providers seamlessly. Antidote's services are particularly beneficial for those in rural areas or individuals with disabilities, addressing the critical need for accessible healthcare solutions. The health plans are primarily available in the states of Arizona and Ohio, catering to a diverse customer base that includes families and individuals seeking affordable healthcare options.Antidote Health's revenue model is based on health insurance premiums from its individual and family plans, which are structured to provide extensive virtual care with no out-of-pocket costs for certain services. Customers enter into agreements by enrolling in these health plans, which may include features such as USD 0 copays for primary care visits and discounted copays for specialist referrals under specific conditions. Transactions typically involve monthly premium payments made by members through the Antidote Member Portal, facilitating a direct-to-consumer relationship. This model is designed to ensure users receive essential medical care while minimizing financial barriers, positioning Antidote Health as a competitive player in the health insurance market. The company’s commitment to simplifying health insurance and improving access to care underscores its mission to provide quality healthcare as a fundamental right.In March 2022, Antidote A.I. Health, Inc. raised USD 22 mn in Series A funding, which will be utilized to support research and development activities, strengthen its market presence, and further expand its services throughout the United States. The company plans to launch new healthcare products aimed at enhancing patient engagement and care accessibility. Future expansion efforts include targeting additional states beyond Arizona and Ohio, although specific regions and timelines for this expansion have not been disclosed.

## Funding rounds

- Series A, Mar 22, 2022, $22M — Flint Capital, Group 11, iAngels
- Seed, Aug 25, 2021, $12M — Flint Capital, iAngels, Welltech Ventures

## Investors

- Flint Capital (https://capitalatlas.ai/funds/flint-capital) — Seed, Series A
- iAngels (https://capitalatlas.ai/funds/iangels) — Seed, Series A
- Welltech Ventures (https://capitalatlas.ai/funds/welltech-ventures) — Seed
- Group 11 (https://capitalatlas.ai/funds/group-11) — Series A